Work

Therapeutic Effects of a Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2B8T2M) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL)

Year: 2017

Type: article

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.3587.3587

Authors: Yaya Chu, Nang Kham Su, Sarah Alter, Emily K. Jeng, Peter R. Rhode, Matthew J. Barth, Dean A. Lee, Hing C. Wong, Mitchell S. Cairo

Institutions: New York Medical College, University at Buffalo, State University of New York, Nationwide Children's Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2944248975

FWCI:

Cites:

Cited by: 1

Related to: 10